Search
naloxone/oxycodone (Targiniq ER)
Indications:
- abuse-deterrent treatment for severe pain
Notes:
- deters abuse via injection and snorting, but it doesn't completely prevent it
General
analgesic combination
References
- FDA News Release. July 23, 2014
FDA approves new extended-release oxycodone with abuse-
deterrent properties.
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm406407.htm
Components
naloxone (Narcan, Evzio, ReVive)
oxycodone (Roxicodone, OxyContin, OxyIR, OxyFast, Oxecta, Xtampza ER)